May 07, 2026 19:07 ET | Source: Cue Biopharma, Inc. BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.…
Sheridan, WY, May 07, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not FDA-approved finished drug products. Novi connects eligible adults…
Aurora, CO, May 06, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration.…
SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the pricing of an…
BEIJING, May 06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…
Former Edgewise and Merck leader brings more than 15 years’ experience to guide Immutrin’s clinical strategy as the Company advances…
May 06, 2026 02:00 ET | Source: Avacta Group PLC LONDON and PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Avacta…
Bagsværd, Denmark, 6 May 2026 - Financial report for the period 1 January 2026 to 31 March 2026 …
~ Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~…
Q1 2026 net revenues increased 10.0%, or 6.5% on a constant currency basis, compared to Q1 2025Q1 2026 net income…